STONY BROOK, NY–July 17, 2018–Applied DNA Sciences, Inc. (Nasdaq: APDN) (“Applied DNA” or the ”Company“), today announced that it received and shipped a $1.15 million order in its fiscal 2018 third quarter ended June 30, 2018 to tag cotton in the upcoming 2018/2019 ginning season. The order for the Company’s SigNature T® platform technology will be used to tag, test and track three US cotton varietals, Pima, Acala and Delta.
“We are pleased that ongoing efforts to build the market for tagged, traceable and sustainable cotton are converting into new orders across all three main US varietals, reflecting recurring use of tagged cotton across the home textile category,” said Dr. James A. Hayward, president and CEO of Applied DNA. “As brands and retailers continue to deploy strategies and technologies to ensure brand protection, label compliance and consumer assurance, our molecular taggant technology platform is ideally positioned to protect their supply chains by providing assurance of quality and provenance, and helps brands guarantee claims with certainty.”
Since 2014, over 200 million lbs of cotton have been tagged, representing the source of a total end-to-end traceability solution that is substantiated by forensic test data. Well over 5,000 DNA tests have been conducted on cotton tagged for the past 4 years. SigNature T technology utilizes fully-automated DNA Transfer Systems in the “Industrial Internet of Things” design that have been installed in 9 gins including one used this season to tag Australian cotton. The additional orders have not yet been received for the 2018/2019 ginning season.
“The database of information we collect from the tagging and testing of cotton fiber now reaches into the millions of data points covering bale identity, spray quality and supply chain testing metrics to ensure true cotton integrity that can be preserved from source to the retail level, continued Dr. Hayward. “The global implementation of proper controls for segregation of cotton at the gin all the way to finished goods ensures total traceability with no room for substitution.”
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics, personalized medicine and therapeutics.
Applied DNA makes life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT®” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.
SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopiable, security and authentication solutions, targeted a wide range of industries, including but not limited to, pharmaceuticals and nutraceuticals, textiles and defense materials, and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. Our products provide a forensic chain of evidence in large commercial ecosystems.
Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.
The statements made by Applied DNA in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe Applied DNA’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA. Actual results could differ materially from those projected due to our lack of significant revenues, limited financial resources, limited market acceptance, history of net losses, market competition, risk of not obtaining regulatory approval and various other factors detailed from time to time in Applied DNA’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 28, 2017 and our subsequent quarterly reports on Form 10-Q filed on February 8, 2018 and May 3, 2018, which are available at www.sec.gov. Applied DNA undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.
Investor contact: Sanjay M. Hurry, 212-838-3777, LHA Investor Relations, shurry@lhai.com
Media contact: Angie Mathews, 781-639-4924, angie@cgprpublicrelations.com
Program contact: MeiLin Wan, 631-240-8849, meilin.wan@adnas.com
Web: www.adnas.com
Twitter: @APDN
